Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05454124 · ClinicalTrials.gov registry record · NA
Factors in Learning And Plasticity: Macular Degeneration
A NA study of Macular Degeneration and Central Visual Impairment, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05454124 is a NA study of Macular Degeneration and Central Visual Impairment that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 60 participants, below the 177-participant average among 26 other Macular Degeneration trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05454124, a NA study of Macular Degeneration and Central Visual Impairment, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
A greater understanding of plasticity after central vision loss can inform new therapies for treating low vision and has the potential to benefit millions of individuals suffering from low vision. The treatment of low vision is particularly relevant to the mission of the NEI to support research on visual disorders, mechanisms of visual function, and preservation of sight. The comparison of different training and outcome factors is in line with the NIMH RDOC framework and studies in an aging population are consistent with the mission of the NIA.
Conditions Studied
Interventions
- BEHAVIORAL Training visual sensitivity
- BEHAVIORAL Combination training
Study Locations (1)
Alabama
- UAB - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-11-01 |
| Est. Completion | 2026-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05454124
The ClinicalTrials.gov registry entry for NCT05454124 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 177-participant average among 26 other Macular Degeneration trials with a reported enrollment target (66% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Macular Degeneration appearing as the primary indexed condition, and to 2 interventions - of which Training visual sensitivity is the first listed.
NCT05454124 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT05454124 about?
NCT05454124 is a clinical study titled "Factors in Learning And Plasticity: Macular Degeneration". A greater understanding of plasticity after central vision loss can inform new therapies for treating low vision and has the potential to benefit millions of individuals suffering from low vision. The treatment of low vision is particularly relevant to the mission of the NEI to support research on v...
What is the current status of trial NCT05454124?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2022-11-01. Estimated completion is 2026-11.
What conditions does trial NCT05454124 study?
This clinical trial studies the following conditions: Macular Degeneration, Central Visual Impairment.
What interventions are being tested in trial NCT05454124?
The interventions under investigation include: Training visual sensitivity (BEHAVIORAL), Combination training (BEHAVIORAL).
Who is sponsoring clinical trial NCT05454124?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05454124 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Macular Degeneration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Factors in Learning And Plasticity: Healthy Vision
ACTIVE NOT RECRUITING · NA
-
Pilot Study: A Randomized Trial Of Anesthetic Agents For Intravitreal Injection
COMPLETED · NA
-
Evaluation of a New Eye-specific Multivitamin Formula in Participants at Risk of Age-related Macular Degeneration (AMD)
COMPLETED · NA
-
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
RECRUITING · Phase 2
-
Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium
RECRUITING · Early Phase 1
-
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.